clinical lab test references
BiomarkersLabs.com

Lab Testing for Practitioners

BML-FSA-005food sensitivity allergyUSA

144 Food Panel: IgA/IgG4

The 144 Food Panel measures IgA and IgG4 antibodies to 144 foods via dried blood spot, positioned by functional practitioners as a tool to identify delayed or non-IgE food sensitivities. Mainstream allergy guidelines regard IgG4 as a marker of exposure rather than pathogenic sensitivity; results are best used as hypothesis-generating data within a supervised elimination-reintroduction protocol.

2

Biomarkers

Dried blood spot

Sample

10–14 business days

Turnaround

No

Fasting

What is the 144 Food Panel test?

The 144 Food Panel measuring IgA and IgG4 antibodies to a broad array of foods is positioned as a tool to identify delayed or non-IgE-mediated food sensitivities that may contribute to gastrointestinal symptoms, fatigue, headache, joint pain, and skin complaints. It is most often ordered by integrative, functional-medicine, and naturopathic practitioners working with patients whose symptoms have not been explained by conventional allergy or gastroenterology evaluation. The test quantifies antibodies to 144 individual foods using dried blood spot technology, yielding a reactivity profile that guides targeted elimination diets. Proponents argue that removing high-reactive foods can reduce systemic inflammation and symptom burden, while mainstream allergy organisations caution that IgA and IgG4 titres reflect exposure and mucosal immune activity rather than causative hypersensitivity, and that panels of this kind have not been validated against double-blind placebo-controlled food challenges — the reference standard for diagnosis.

What does the 144 Food Panel test measure?

1
IgA(Food-Specific Immunoglobulin A)
Range: Laboratory-specific class scale (typically 0–3 or 0–4); results reported per food as negative, borderline, or reactive in graded tiers.Optimal: Class 0 or negative across the panel is considered non-reactive; higher classes indicate increasing antibody titre, though thresholds for clinical action are not standardised.Arbitrary units / Optical density

Immunoglobulin A is the dominant antibody class at mucosal surfaces, where the secretory form (sIgA) prevents antigen penetration and modulates immune tolerance. Serum IgA to foods can reflect mucosal immune activation or breakdown of oral tolerance, though the relationship between serum titres and gastrointestinal symptoms remains contested. Unlike IgE-mediated reactions, IgA responses are not associated with immediate-type allergy.

Elevated food-specific IgA is interpreted by some practitioners as a marker of delayed or 'hidden' sensitivity contributing to gastrointestinal or systemic symptoms, particularly when mucosal barrier integrity is compromised. The clinical validity of this association is debated, and IgA reactivity does not predict the outcome of a supervised oral challenge.

2
IgG4(Food-Specific Immunoglobulin G Subclass 4)
Range: Laboratory-specific class scale; results reported per food as negative, borderline, or reactive in graded tiers.Optimal: Class 0 or negative is non-reactive; clinical interpretation of elevated IgG4 is operator-dependent and should not replace structured dietary trial or supervised challenge.Arbitrary units / Optical density

IgG4 is an unusual IgG subclass that does not fix complement and has low affinity for Fc receptors, properties that render it functionally anti-inflammatory. In the context of allergen immunotherapy and chronic antigen exposure, IgG4 is thought to reflect immune tolerance rather than sensitisation. Elevated food-specific IgG4 may simply mark frequent consumption of that food.

The use of IgG4 (and total IgG) testing to diagnose food intolerance is not endorsed by allergy academies, which regard IgG4 as a marker of exposure or tolerance rather than a pathogenic antibody. Nonetheless, some functional and integrative practitioners order IgG4 panels as part of elimination-challenge protocols, interpreting elevated titres as candidates for temporary withdrawal.

Why is the 144 Food Panel test ordered?

  • Investigation of chronic gastrointestinal symptoms (bloating, altered bowel habit, discomfort) when coeliac disease, inflammatory bowel disease, and IgE-mediated allergy have been excluded
  • Patients reporting multiple, vague, or systemic symptoms (fatigue, brain fog, joint pain, skin eruptions) attributed to diet but without a clear pattern on dietary history
  • Functional or integrative management of irritable bowel syndrome phenotypes where a structured elimination diet is being planned and antibody reactivity will inform food selection
  • Assessment of suspected non-IgE food hypersensitivity in the context of autoimmune or inflammatory conditions, when the practitioner is exploring dietary triggers
  • Paediatric patients with eczema, recurrent upper respiratory or ear symptoms, or behavioural concerns where parents report food-related exacerbations and the clinician wishes to guide a trial of elimination
  • Baseline mapping for patients beginning a therapeutic elimination protocol (such as autoimmune paleo or low-antigen diet), with the understanding that results are hypothesis-generating rather than diagnostic

Sample collection and turnaround

Sample type

Dried blood spot

Fasting required

No

Collection method

Finger prick

Turnaround

10–14 business days

Collection notes

At-home finger-prick collection onto a filter-paper card supplied in the kit. The patient lances a fingertip, deposits blood drops into the marked circles, air-dries the card completely (typically 2–4 hours at room temperature), and returns it by post in the envelope provided. Collection should occur when the patient is consuming the foods of interest — a period of deliberate reintroduction before testing may be needed if foods have been eliminated.

Specimen requirements

Complete filling of all indicated circles on the dried blood spot card; insufficient volume or partial saturation may require recollection. The card must be fully dried before sealing to prevent microbial growth or antibody degradation. Avoid exposure to heat or direct sunlight during drying or transit.

What can affect 144 Food Panel results?

reducesRecent or current dietary avoidance of a food

Antibody titres fall when an antigen is withdrawn, so recent elimination of a food may yield a false-negative result; a reintroduction challenge before testing improves sensitivity.

reducesImmunoglobulin deficiency (selective IgA deficiency or hypogammaglobulinaemia)

Patients with selective IgA deficiency will show low or absent IgA responses across the panel, rendering that arm of the test uninformative; total immunoglobulin quantitation should be reviewed.

variableRecent infection, vaccination, or systemic inflammation

Polyclonal immune activation can transiently alter antibody levels, though the magnitude of effect on food-specific titres is uncertain.

elevatesCross-reactive carbohydrate determinants and other epitopes

Some plant glycoproteins carry cross-reactive carbohydrate epitopes that bind IgG non-specifically, potentially inflating reactivity scores without clinical relevance.

elevatesHigh recent intake of a tested food

Frequent consumption drives antibody production, so elevated IgG4 may simply reflect a staple food rather than an intolerance; correlation with symptoms is required.

variableSpecimen quality (inadequate blood volume or haemolysis of the dried spot)

Insufficient or degraded samples may yield indeterminate or low-titre results; proper finger-prick technique and prompt drying are essential.

What do 144 Food Panel results mean?

Elevated

Class 2–4 (or equivalent high-titre) IgA or IgG4 to a food indicates measurable antibody response. In the model used by practitioners ordering this panel, such reactivity is a candidate for temporary elimination (typically four to six weeks) followed by supervised reintroduction to assess symptom correlation. It is not a diagnosis of allergy or intolerance — it is a screening signal to be tested clinically.

Normal

A predominantly non-reactive or low-reactive panel does not exclude food intolerance — symptoms may be mediated by non-immune mechanisms (fermentation, osmotic effects, pharmacological amines) or by foods not included in the panel. Clinical correlation remains paramount.

Reduced

Class 0 or non-reactive results across the panel suggest that the tested foods are not driving significant IgA or IgG4 responses. Low or absent IgA across all foods should prompt review of total serum IgA to exclude selective deficiency.

Note: The clinical validity of IgA/IgG4 food panels is contested. Major allergy societies state that IgG/IgG4 is a marker of exposure, not disease, and that such tests should not replace history, dietary trial, or supervised challenge. Use these results as hypothesis-generating data within a structured elimination-reintroduction protocol, not as standalone diagnostic evidence. Inform patients that elevated antibodies do not guarantee symptom causation and that the most reliable test is a supervised dietary challenge.

Frequently asked questions

IgE testing detects immediate-type allergic reactions (urticaria, anaphylaxis). IgA and IgG4 panels measure antibodies that reflect mucosal immune activity and food exposure; some practitioners interpret elevated titres as delayed sensitivities, but major allergy organisations state that IgG4 is a marker of tolerance or exposure, not disease.

How to access the 144 Food Panel test

The 144 Food Panel reference page is free and open to all practitioners. Create a free practitioner account to see pricing, save tests to your list, and generate requisition forms. Verification takes 1–2 business days.

Create Free Account

About this page

Published: October 7, 2026

Last reviewed: October 7, 2026

References:
  1. Stapel SO, et al. Testing for IgG4 against foods is not recommended as a diagnostic tool: EAACI Task Force Report. Allergy. (2008)
  2. Carr S, Chan E, Lavine E, Moote W. CSACI position statement on the testing of food-specific IgG. Allergy Asthma Clin Immunol. (2012)
  3. Heine RG. Food allergy prevention and treatment by targeted nutrition. Ann Nutr Metab. (2018)
  4. Ligaarden SC, Lydersen S, Farup PG. IgG and IgG4 antibodies in subjects with irritable bowel syndrome: a case-control study in the general population. BMC Gastroenterol. (2012)
  5. American Academy of Allergy, Asthma & Immunology. AAAAI statement on IgG testing for food allergy. (2020)

This content is for licensed healthcare practitioners only and does not constitute medical advice. Clinical decisions should be based on the full clinical picture and not on any single test result.